Guillain-Barre syndrome following COVID-19 vaccines: a scoping review (2022)
Source: Acta neurologica scandinavica. Unidade: FM
Subjects: COVID-19, VACINAS VIRAIS, FATORES DE RISCO
ABNT
FERNANDEZ, Paulo Eduardo Lahoz et al. Guillain-Barre syndrome following COVID-19 vaccines: a scoping review. Acta neurologica scandinavica, v. 145, n. 4, p. 393-398, 2022Tradução . . Disponível em: https://doi.org/10.1111/ane.13575. Acesso em: 17 out. 2024.APA
Fernandez, P. E. L., Pereira, J. M., Risso, I. F., Silva, P. B. R., Barboza, I. C. F., Silveira, C. G. V., et al. (2022). Guillain-Barre syndrome following COVID-19 vaccines: a scoping review. Acta neurologica scandinavica, 145( 4), 393-398. doi:10.1111/ane.13575NLM
Fernandez PEL, Pereira JM, Risso IF, Silva PBR, Barboza ICF, Silveira CGV, Silva GD, Puglia PMK, Mutarelli EG. Guillain-Barre syndrome following COVID-19 vaccines: a scoping review [Internet]. Acta neurologica scandinavica. 2022 ; 145( 4): 393-398.[citado 2024 out. 17 ] Available from: https://doi.org/10.1111/ane.13575Vancouver
Fernandez PEL, Pereira JM, Risso IF, Silva PBR, Barboza ICF, Silveira CGV, Silva GD, Puglia PMK, Mutarelli EG. Guillain-Barre syndrome following COVID-19 vaccines: a scoping review [Internet]. Acta neurologica scandinavica. 2022 ; 145( 4): 393-398.[citado 2024 out. 17 ] Available from: https://doi.org/10.1111/ane.13575